Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review

AIM. To determine the optimal strategy of chemotherapy for patients with relapsed/refractory (r/r) primary mediastinal (thymic) large B-cell lymphoma (PMBCL). MATERIALS & METHODS. The study is based on the clinical data from 26 patients with r/r PMBCL treated at the NN Blokhin National Medical Ca...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Arman Vachakanovich Arakelyan, G. S. Tumyan, A. A. Semenova, M. Yu. Kichigina, I. Z. Zavodnova, D. N. Tupitsyna, E. V. Paramonova, A. S. Antipova, V. O. Shpirko, Yu. I. Klyuchagina, S. F. Ramazanova, U. G. Koshkina, I. S. Monin, N. M. Zolotaikina, G. D. Petrova, O. P. Trofimova, A. S. Subbotin, M. A. Senchenko, V. Yu. Kirsanov
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Practical Medicine Publishing House 2025-01-01
Serie:	Клиническая онкогематология
Soggetti:	primary mediastinal (thymic) large b-cell lymphoma relapse refractoriness immunochemotherapy radiotherapy auto-hsct
Accesso online:	https://bloodjournal.ru/index.php/coh/article/view/113
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!